首页> 外文期刊>Urology >Preperitoneal robotic prostate adenomectomy.
【24h】

Preperitoneal robotic prostate adenomectomy.

机译:腹膜前机器人前列腺腺切除术。

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVES: To describe the surgical technique and evaluate the feasibility of robotic-assisted preperitoneal prostate adenomectomy for large benign adenomas in a pilot series. METHODS: A total of 13 consecutive patients with a median age 70 years and body mass index of 26 kg/m(2) in whom open adenomectomy was planned were included in this pilot study. The extraperitoneal robotic approach was standardized in all cases. The demographic, operative, and outcome measurements were analyzed. The conversion rate, total operative time, and blood loss served as the feasibility parameters. RESULTS: The total operative time was 210 minutes (range 150-330). No open conversion was necessary. The blood loss was 500 mL (range 100-1100), with a 0% transfusion rate. Single-finger assistance improved the total operative time to 140 minutes (range 110-180; P = .007) and blood loss to 250 mL (range 200-350; P = .02). The specimen weight was 82 g (range 50-150). The indwelling catheters were removed after 6 days (range 3-15), and the patients returned to work after 13 days (range 8-17). After a median follow-up of 13 months (range 2-18), the patients had a median flow rate of 23 mL/s without any postvoid residual urine. CONCLUSIONS: The results of our study have shown that preperitoneal robotic transvesical prostate adenomectomy is a feasible and reproducible procedure. Additional series with larger patient cohorts and prostate adenomas are needed.
机译:目的:在一系列试验中,描述手术技术并评价机器人辅助腹膜前前列腺腺切除术治疗大型良性腺瘤的可行性。方法:该计划纳入了13例中位年龄为70岁且体重指数为26 kg / m(2)的连续患者,其中计划行开放性腺切除术。在所有情况下,腹膜外机器人方法都是标准化的。人口统计,手术和结果测量进行了分析。转换率,总手术时间和失血作为可行性参数。结果:总手术时间为210分钟(范围150-330)。无需公开转换。失血量为500毫升(范围100-1100),输血率为0%。单指辅助将总手术时间缩短至140分钟(范围为110-180; P = .007),失血量为250 mL(范围为200-350; P = .02)。样品重量为82g(范围50-150)。 6天后(3-15范围)拔出留置导管,患者在13天后(8-17范围)恢复工作。在中位随访13个月(范围2-18)后,患者的中位流速为23 mL / s,无残留尿。结论:我们的研究结果表明,腹膜前机器人经膀胱膀胱前列腺切除术是一种可行且可重复的方法。需要具有更大患者队列和前列腺腺瘤的其他系列。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号